Differences in need for antihypertensive drugs among those aware and unaware of their hypertensive status: a cross sectional survey
- PMID: 15691376
- PMCID: PMC548688
- DOI: 10.1186/1471-2261-5-4
Differences in need for antihypertensive drugs among those aware and unaware of their hypertensive status: a cross sectional survey
Abstract
Background: Lack of antihypertensive use among hypertensive individuals is a major public health problem. It remains unclear as to how much of this lack of treatment is because of failure to diagnose hypertension or failure to initiate drug treatment for those with a diagnosis of hypertension. The primary aim of this study was to determine the proportion of those untreated individuals who would be recommended to start drug therapy for control of blood pressure among those aware or unaware of their diagnosis of hypertension.
Methods: The Canadian Heart Health Surveys (1986-1992), a national, cross-sectional descriptive survey (n = 23,129), was used to determine the proportion of individuals who were untreated, yet satisfied the 2004 Canadian hypertension guidelines for initiating drug therapy. Patients were divided into subgroups of those aware and unaware of having a diagnosis of hypertension according to self reported awareness from the survey.
Results: Of those with untreated hypertension (= 140/90 mmHg), only 37% were aware of their diagnosis. 74% of untreated individuals aware of their diagnosis of hypertension would require drug therapy, compared to 57% of those who were unaware. Of those >65 years of age, 52% of aware individuals needed drug therapy whereas only 34% of unaware elderly would need drug treatment.
Conclusion: In both unaware and aware subgroups, the majority of patients with untreated hypertension would benefit from antihypertensive drug therapy according to the 2004 Canadian Hypertension recommendations. The proportion of untreated patients that still need drug therapy was higher among those who were aware compared to those who were unaware. This finding suggests that the major gap in hypertension control may be in initiating drug therapy rather than in diagnosing hypertension. Further studies are needed to confirm these results to ultimately help strategize public health efforts in controlling hypertension.
Similar articles
-
Lack of control of high blood pressure and treatment recommendations in Canada.Can J Cardiol. 2002 Jun;18(6):657-61. Can J Cardiol. 2002. PMID: 12107423
-
Awareness and misconception of hypertension in Canada: results of a national survey.Can J Cardiol. 2005 May 15;21(7):589-93. Can J Cardiol. 2005. PMID: 15940357
-
Gender differences in hypertension treatment, drug utilization patterns, and blood pressure control among US adults with hypertension: data from the National Health and Nutrition Examination Survey 1999-2004.Am J Hypertens. 2008 Jul;21(7):789-98. doi: 10.1038/ajh.2008.185. Epub 2008 May 1. Am J Hypertens. 2008. PMID: 18451806
-
Physicians, patients, and public knowledge and perception regarding hypertension and stroke: a review of survey studies.Curr Med Res Opin. 2006 Jul;22(7):1319-30. doi: 10.1185/030079906X112570. Curr Med Res Opin. 2006. PMID: 16834831 Review.
-
Prevalence, awareness, treatment and control of hypertension in North America, North Africa and Asia.J Hum Hypertens. 2004 Aug;18(8):545-51. doi: 10.1038/sj.jhh.1001701. J Hum Hypertens. 2004. PMID: 15269704 Review.
Cited by
-
The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.Can J Cardiol. 2010 May;26(5):249-58. doi: 10.1016/s0828-282x(10)70379-2. Can J Cardiol. 2010. PMID: 20485689 Free PMC article. Review.
-
The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2--therapy.Can J Cardiol. 2009 May;25(5):287-98. doi: 10.1016/s0828-282x(09)70492-1. Can J Cardiol. 2009. PMID: 19417859 Free PMC article. Review.
References
-
- MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335:765–74. doi: 10.1016/0140-6736(90)90878-9. - DOI - PubMed
-
- Gueyffier F, Boutitie F, Boissel JP, Pocock S, Coope J, Cutler J, Ekbom T, Fagard R, Friedman L, Perry M, Prineas R, Schron E. Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomized, controlled trials. The INDANA Investigators. Ann Intern Med. 1997;126:761–7. - PubMed
-
- Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, Godwin J, Qizilbash N, Taylor JO, Hennekens CH. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet. 1990;335:827–38. doi: 10.1016/0140-6736(90)90944-Z. - DOI - PubMed
-
- Khan NA, McAlister FA, Campbell NR, Feldman RD, Rabkin S, Mahon J, Lewanczuk R, Zarnke KB, Hemmelgarn B, Lebel M, Levine M, Herbert C, Canadian Hypertension Education Program The 2004 Canadian recommendations for the management of hypertension: Part II – Therapy. Can J Cardiol. 2004;20:41–54. - PubMed
-
- Khan N, Chockalingam A, Campbell NR. Lack of control of high blood pressure and treatment recommendations in Canada. Can J Cardiol. 2002;18:657–61. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous